USA – Visby Medical, a San Jose, CA-based medical diagnostic company, raised over $100m in Series E financing round.
The round was led by Ping An Voyager Partners, joined by the Healthcare of Ontario Pension Plan (HOOPP), with participation from existing investors John Doerr, Cedars Sinai Medical Center, ND Capital, Artiman Ventures, Pitango Venture Capital, Blue Water Life Science Advisors and Nissim Capital. The company intends to use the funds to scale production capacity from tens to hundreds of thousands of tests per month, further expand the product menu to include COVID + influenza A/B combination testing, antimicrobial resistance panels, and deliver PCR diagnostics to consumers at-home.Led by Founder and CEO Adam de la Zerda, PhD, Visby Medical has developed an instrument-free, palm-sized, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. The technology is also helping to fight the global pandemic via the Visby Medical COVID-19 Test, and its pipeline includes tests for other infectious diseases. Visby Medical is accelerating the delivery of PCR diagnostics to the point of care, and eventually for use at home.02/03/2022
